Fixed Dose Combination Orally Disintegrating Tablets to Treat Cardiovascular Disease: Formulation, in vitro Characterization and Physiologically Based Pharmacokinetic Modelling to Assess Bioavailability



Collection Method: The Excel files contain dissolution data for both single and FDC formulations, which have been corrected for samples withdrawn under sink conditions. Data is also included for Caco-2 drug permeability studies and show the mass transfer of drug from both A-B and B-A directions over the study period

Funding: Medical Research Council (MR/J01236X/1)
Date made available3 Feb 2017
PublisherAston Data Explorer

Cite this